|
|  | | | News |  | | Nature Biotechnology
22, 1057 - 1058 (2004)
Published online: 27 August 2004; | doi:10.1038/nbt0904-1057
There is an Errata (December 2004) associated with this News.
Cash-strapped biotechs find financing alternativePeter Mitchell
London
Publicly quoted biotech companies increasingly rely on private investors to raise money
|
| | |
